Table 2.
Vaccinated patients (n = 82) |
Control group (n = 82) |
p-value | |
---|---|---|---|
Presentation symptoms | |||
Fever | 36 (43.9) | 42 (51.2) | 0.348 |
Cough | 52 (65.9) | 49 (59.8) | 0.426 |
Dyspnea | 20 (25.3) | 18 (22) | 0.615 |
Diarrhea | 28 (34.1) | 16 (19.5) | 0.034 |
Initial examination findings | |||
Pulse rate (/min) | 60 (60–64) | 78 (60–90) | <0.001 |
SpO2 value (%) | 98 (95–99) | 98 (95–99) | 0.687 |
Respiratory rate (/min) | 18 (16–18) | 18 (18–20) | 0.004 |
Blood pressure (mmHg) | |||
Systolic | 110 (110–120) | 120 (110–125) |
0.003 |
Diastolic | 80 (70–80) | 80 (78–80) | 0.022 |
Laboratory results at admission | |||
Serum creatinine (mg/dL) | 1.2 (0.9–1.6) | 1.3 (1–1.7) | 0.465 |
Leucocyte count (/mm3) | 6000 (4500–8100) | 6650 (4690–8340) | 0.540 |
Lymphocyte count (/mm3) | 1060 (760–1600) | 900 (560–1370) | 0.173 |
Hemoglobin (g/dL) | 13 (11.3–14) | 12.8 (11.3–14) | 0.530 |
Platelet count (/mm3) | 196 (159–258) | 205 (152–271) | 0.521 |
Serum CRP levels (mg/L) | 16 (6–35) | 18 (3–46) | 0.972 |
Serum ALT levels (IU/L) | 21 (15–30) | 18 (14–24) | 0.274 |
Serum AST levels (IU/L) | 22 (17–32) | 20 (17–27) | 0.138 |
Serum LDH levels (IU/L) | 215 (184–261) | 238 (186–307) | 0.243 |
Serum D-dimer (ng/mL) | 338 (179–658) | 420 (305–772) | 0.057 |
Serum Ferritin (ng/mL) | 232 (111–573) | 326 (99–646) | 0.556 |
Serum Albumin (g/dL) | 4.1 (3.6–4.4) | 3.7 (3.4–4.2) | 0.024 |
Serum IL-6 (pg/mL) | 1.5 (1.1–11) | 1.6 (0.8–4.5) | 0.637 |
Procalcitonin (ng/mL) | 0.08 (0.04–0.21) | 0.08 (0.04–0.53) | 0.953 |
Abbreviations: SpO2: blood oxygen saturation levels; CRP: C-reactive protein; ALT: alanine aminotransferase; AST: aspartate aminotransferase; LDH: lactate dehydrogenase; IL-6: Interleukin 6. P-values compared vaccinated patients and control group, obtained from the Chi-Square test, Fisher’s exact test, or Mann–Whitney U test. Data were presented as n (%) or median [Interquartile range 25–75] unless otherwise noted. Bold indicates statistically significant associations (p < 0.05).